Efficacy of Ponatinib Versus Earlier Generation Tyrosine Kinase Inhibitors for Front-line Treatment of Newly Diagnosed Philadelphia-positive Acute Lymphoblastic Leukemia

201857 citationsReview

Authors

Good health and well-being

Published in: Clinical Lymphoma Myeloma & Leukemia

Volume 18, Issue 4, pp. 257-265

Field-Weighted Citation Impact: 4.08